(Alliance News) - Omega Diagnostics Group PLC on Monday announced that its Visitect CD4 Advanced Disease test will be included in the Global Fund procurement list. Shares in Omega Diagnostics were up ...

(Sharecast News) - Medical diagnostics company Omega Diagnostics has successfully manufactured three validation batches of its 'VISITECT CD4' advanced disease test, it announced on Tuesday. The ...

VISITECT® CD4, developed by the Burnet Institute in Melbourne, Australia, is an affordable POC test that enables CD4 T-cell levels to be determined, quickly and conveniently, even in remote rural ...

Omega Diagnostics, the medical testing developer that recently sold its Scottish manufacturing facility, has agreed terms for the sale of its CD4 testing business. Did you know with a Digital ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

The Visitect CD4 test manufacturing protocol has been set with three test batches to be made and tested for consistency. If Visitect leaps this hurdle, pilot studies could start in H114 with ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

H113. Performance was mixed with food intolerance 9% higher, infectious disease down 12% and allergy steady at 2%. On 31 October the company gave the latest Visitect CD4 test manufacturing update, ...